BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Topics
» Neurology/psychiatric, BioWorld Science
Neurology/psychiatric, BioWorld Science
RSS
New data on Novartis' competitive NMDA 1A/2A receptor antagonist
Nov. 21, 2005
Preclinical data on GSK's new TRPV1 antagonist
Nov. 21, 2005
Escitalopram reported effective in patients with obsessive-compulsive disorder
Nov. 21, 2005
AC-260584: an atypical M1 agonist with an ectopic binding site
Nov. 18, 2005
ABT-127: Abbott's new D3 receptor antagonist targeted as an antipsychotic
Nov. 18, 2005
Xenome begins phase I/II study for XEN-2174 for severe intractable pain
Nov. 18, 2005
Antidepressant effects of two new triple reuptake inhibitors
Nov. 18, 2005
Pfizer's new nNOS inhibitors demonstrate efficacy for pain and stroke
Nov. 18, 2005
Novel lactam sodium channel blocker displays anticonvulsant activity
Nov. 18, 2005
New treatments for neuropsychiatric disorders claimed in recent patent literature
Nov. 17, 2005
Previous
1
2
…
1812
1813
1814
1815
1816
1817
1818
1819
1820
…
2788
2789
Next
RSS